市場調査レポート
商品コード
1417598
眼科用レーザーの世界市場の評価:製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Ophthalmic Lasers Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
眼科用レーザーの世界市場の評価:製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年01月29日
発行: Market Xcel - Markets and Data
ページ情報: 英文 232 Pages
納期: 3~5営業日
|
世界の眼科用レーザーの市場規模は、2023年に15億1,000万米ドル、2031年に23億8,000万米ドルに達し、2024年~2031年の予測期間にCAGRで5.86%の成長が見込まれています。世界の眼科用レーザー市場は、眼科デバイス市場の中で急成長している市場です。世界の眼科用レーザー市場は、眼科疾患の有病率の増加、老年人口の増加、レーザーデバイスの技術の進歩などの要因によって牽引されています。眼科患者数は、長いスクリーンタイム、ライフスタイルの変化、栄養不足、慢性疾患などの要因によって世界的に増加しています。これらの要因は、眼科用レーザーデバイスの巨大な需要を促進しています。
老年人口の増加は、視力障害を必要とする人々の数を増加させると予測されています。さらに、糖尿病や高血圧などの慢性疾患の有病率の増加は、眼科疾患が慢性疾患の主な併存疾患であることから、レーザデバイスの需要を引き込むと予測されています。設計の最適化、機能性の向上、副作用の低減など、多くの技術の進歩が眼科用レーザーデバイスの需要拡大に寄与しています。政府の有利な政策が医療インフラと医療機器の供給を強化し、市場を促進しています。レーザー眼科治療は従来の治療法に対し、痛みが少ない、効果が高い、入院期間が短い、切開の必要がないなどの複数の利点があるため、白内障、AMD、緑内障などの眼科疾患の管理に好まれています。しかし、レーザー治療の高いコストや熟練した専門家の不足といった要因が、予測期間中の市場成長を妨げる可能性があります。
2023年4月、Johnson & Johnson Visionは、新しいELITA Femtosecond LaserのFDA 510(k)の認可を取得したと発表しました。Johnson & Johnson Visionは、過去20年にわたり眼科機器産業をリードしており、有望な製品ポートフォリオを有しています。ELITA Femtosecondレーザーフラップは、1パルスあたりのエネルギーが低く、超高速のレーザー繰り返し速度と小さなスポットサイズで、外科医のスピードと精度を向上させます。
不健康なライフスタイル、栄養不足、長いスクリーンタイムによる眼科疾患の有病率の増加が眼科用レーザー市場の需要を促進しています。もっとも一般的な眼科疾患には、近視、屈折異常、白内障、糖尿病網膜症、緑内障、加齢黄斑変性などがあります。このような疾患に対しては、レーザー治療が有効であることが証明されており、術後のケア期間も短くて済むことから、ほとんどの外科医がレーザー治療を推奨しています。
例えば、WHOが2023年8月に発表したファクトシートによると、世界中で約22億人が近方視力障害または遠方視力障害に苦しんでおり、そのうち約10億人が遠方視力障害、10億人が白内障による失明、8,840万人が屈折異常、800万人が加齢黄斑変性、770万人が緑内障、390万人が糖尿病性網膜症を患っています。近方視力障害の主な原因は老眼で、その患者数は約8億2,600万人です。
眼科疾患に罹患しやすい老年人口の増加が、眼科用レーザー治療の需要を大きく促進しています。加齢に伴い、加齢関連要因による眼科疾患の可能性が高まります。日本のような国々は高齢者が非常に多いため、市場シェアの大部分を占めています。WHOのデータによると、2030年までに世界の6人に1人が60歳以上になり、合計で14億人になると予測されています。WHOは2020年に老年人口を10億人と推定しています。その数は2050年までに2倍になると予測されています。2020年~2050年に、80歳以上の人口は4倍になり、約4億2,600万人に達すると予測されています。National Health and Aging Trends Studyによると、米国では71歳以上の成人の27.8%が視覚障害を持っています。
当レポートでは、世界の眼科用レーザー市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。
Global ophthalmic lasers market size was valued at USD 1.51 billion in 2023, and is expected to reach USD 2.38 billion in 2031, with a CAGR of 5.86% for the forecast period between 2024 and 2031F. The global ophthalmic lasers market is a fast-growing market within the ophthalmic devices market. The global ophthalmic lasers market is driven by factors such as the growing prevalence of ophthalmic disorders, rising geriatric population, and technological advancements in laser devices. The number of ophthalmic patients is increasing globally owing to factors such as longer screen time, lifestyle changes, lack of nutrition, and chronic diseases. These factors are driving huge demand for ophthalmic laser devices.
Growth in geriatric population is expected to increase the number of people who require vision impairment. Additionally, the growing prevalence of chronic diseases, such as diabetes and hypertension, are expected to draw demand for laser devices as ophthalmic disorders are prominent comorbidities with chronic diseases. Technological advancements like design optimization, functionality improvement, reducing side effects, and many others are favoring the growth in demand for ophthalmic laser devices. Favorable government policies strengthen the healthcare infrastructure and medical device availability, promoting the market. Laser ophthalmic treatments have several benefits over conventional treatment methods such as less pain, high effectivity, shorter hospital stay, and no need for incision, thus preferred over conventional methods for managing ophthalmic diseases like cataracts, AMD, and glaucoma. However, factors like the high cost of laser therapies and the lack of skilled professionals may hinder market growth during the forecast period.
In April 2023, Johnson & Johnson Vision announced that it had received FDA 510(k) clearance for its new ELITA Femtosecond Laser FDA 510(k) clearance to create LASIK flaps. Johnson & Johnson Vision has been a leader in the ophthalmic devices industry for the last two decades with a promising product portfolio. The ELITA Femtosecond laser flap offers low energy per pulse, with ultra-fast laser repetition rate and small spot size, facilitating the surgeon's speed and accuracy.
The growing prevalence of ophthalmic disorders due to unhealthy lifestyles, nutritional deficiency, and longer screen time is driving the demand in the ophthalmic lasers market. Most common ophthalmic disorders include myopia, refractive errors, cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration. Most surgeons recommend laser treatments for such diseases as they are proven effective and require a shorter post-operative care period.
For instance, according to a factsheet published by WHO in August 2023, around 2.2 billion individuals are suffering from near or distance vision impairment across the globe, out of which approx. 1 billion people suffer from distance vision impairment, 1 billion from blindness with cataracts, 88.4 million from refractive error, 8 million from age-related macular degeneration, 7.7 million from glaucoma, and 3.9 million from diabetic retinopathy. The major defect causing near vision impairment is presbyopia with a number of around 826 million patients.
The growing geriatric population that is highly prone to ophthalmic disorders is significantly driving the demand for ophthalmic laser treatments. With age, the chances of ophthalmic diseases increase due to age-associated factors. Countries such as Japan have a very high number of old age individuals and thus are contributing a major chunk of value share to the market. As per WHO data, by 2030, 1 out of 6 individuals worldwide will be above the age of 60 years, which is expected to be 1.4 billion population in total. WHO estimated 1 billion geriatric population in 2020. The number is expected to double (to 2.1 billion) by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will quadruple, reaching approx. 426 million counts. According to the National Health and Aging Trends Study, 27.8% of United States adults 71 years and older had visual impairments.
The femtosecond laser segment in global ophthalmic lasers is expected to dominate during the forecast period. Femtosecond laser is highly effective for the treatment of cataracts and refractive errors in the eye and, thus, is very commonly used. The growing prevalence of cataracts and technological advancements in femtosecond laser devices are some reasons for their dominance. Market players are investing in femtosecond laser technology to add cutting-edge products to their portfolio. For instance, in February 2023, Fluence announced the launch of Jasper Micro, a new addition to its Jasper range of femtosecond lasers. Jasper Micro is an air-cooled and very compact device with widespread applications like LASIK, PRK, and DNA transfection eye surgeries.
Asia-Pacific is home to developing countries, like India and China, which have a significantly high burden of ophthalmic diseases. The rising geriatric population with a higher affinity to ophthalmic diseases is driving the demand for ophthalmic lasers. The growing investment in the healthcare sector is helping expand the associated markets. Increasing investors' attention towards the region is opening opportunities for market expansion. Demand for efficient ophthalmic equipment in Asia-Pacific is increasing owing to rapidly evolving technologies. Heavy emphasis on preventive care and early intervention for ophthalmic disorders fuels the demand for ophthalmic lasers during the assessment period.
The healthcare infrastructure is developing and getting strengthened in nations across the globe and multiple attempts are being made to reduce the burden of ophthalmic diseases, for example, the integrated people-centered eye care (IPEC) initiative by WHO. Noval technology penetration in ophthalmic laser devices such as developments in femtosecond laser technology, the use of wavefront technology, and the use of adaptive optics are anticipated to strengthen the market dynamics in future years. These advances are anticipated to help surgeons perform more intricate and precise surgeries in the future through highly evolved lasers.
Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using a variety of strategies. To gain market share, companies are expanding their range of products being offered. Industry participants use various growth methods, including collaborations, mergers and acquisitions, product launches, and development of new products, to bolster their positions in the market.
In December 2023, Carl Zeiss Meditec AG announced the agreement to acquire 100% shares of the Dutch Ophthalmic Research Center (DORC) from the France-based investment firm Eurazeo. The deal is valued at EUR 985 million and is expected to close in the first half of 2024. DORC's offer robust portfolio includes devices, disposables, and liquids for ophthalmic surgeries, with prime focus on its dual-function Eva Nexustm platform.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.